Education
About Us
Working with TipRanks
Follow Us
Eden Research PLC (GB:EDEN)
LSE:EDEN
EDEN Stock Chart & Stats
2.60p
-0.12p(-3.03%)
At close: 4:00 PM EST
2.60p
-0.12p(-3.03%)
Day’s Range― - ―
52-Week Range1.96p - 5.00p
Previous CloseN/A
Volume228.48K
Average Volume (3M)564.08K
Market Cap
£21.07M
Enterprise Value19.79M
Total Cash (Recent Filing)£1.85M
Total Debt (Recent Filing)£571.86K
Price to Earnings (P/E)―
Beta1.13
Next Earnings
May 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding533,352,540
10 Day Avg. Volume506,108
30 Day Avg. Volume564,076
Financial Highlights & Ratios
PEG Ratio0.14
Price to Book (P/B)1.78
Price to Sales (P/S)4.90
P/FCF Ratio-5.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Sustainable Product FocusEden's core focus on plant‑based biopesticides positions it in a structurally growing sustainable agriculture market. Durable regulatory and farmer shifts away from synthetic inputs increase long‑term addressable market and support recurring demand for eco‑friendly formulations and licensing.
Partnerships And Licensing RevenueEstablished partnerships and licensing provide diversified go‑to‑market routes and non‑linear revenue streams. Collaborations lower commercialization risk, bring distribution muscle, and can supply R&D funding or royalty income, supporting sustainable growth without sole reliance on internal sales.
Solid Equity PositionA high equity ratio implies low financial leverage and a stronger balance sheet cushion. This durability helps the company absorb operational losses, preserve strategic optionality for R&D and market expansion, and reduces short‑term refinancing pressure versus highly leveraged peers.
Bears Say
Consistent Negative Cash FlowPersistent negative operating and free cash flow indicate ongoing cash burn from operations. Over months this constrains ability to self‑fund growth or commercialization, increases dependency on external financing, and can force dilutive capital raises or restrict investment in scale.
Ongoing UnprofitabilityRepeated negative EBIT and net income show the business has yet to convert revenue into sustainable profits. Continued unprofitability undermines retained earnings, reduces reinvestment capacity and may limit confidence from partners and lenders, slowing long‑term scaleup.
Declining Shareholders' EquityErosion of shareholders' equity from ongoing losses reduces the balance sheet buffer and borrowing headroom. Over time this weakens financial resilience, raises refinancing and solvency risk, and can limit ability to fund product launches or enter new markets without external capital.
Eden Research News
EDEN FAQ
What was Eden Research PLC’s price range in the past 12 months?
Eden Research PLC lowest share price was 1.96p and its highest was 5.00p in the past 12 months.
What is Eden Research PLC’s market cap?
Eden Research PLC’s market cap is £21.07M.
When is Eden Research PLC’s upcoming earnings report date?
Eden Research PLC’s upcoming earnings report date is May 12, 2026 which is in 80 days.
How were Eden Research PLC’s earnings last quarter?
Eden Research PLC released its earnings results on Sep 17, 2025. The company reported -0.002p earnings per share for the quarter, missing the consensus estimate of N/A by -0.002p.
Is Eden Research PLC overvalued?
According to Wall Street analysts Eden Research PLC’s price is currently Overvalued.
Does Eden Research PLC pay dividends?
Eden Research PLC does not currently pay dividends.
What is Eden Research PLC’s EPS estimate?
Eden Research PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eden Research PLC have?
Eden Research PLC has 533,352,540 shares outstanding.
What happened to Eden Research PLC’s price movement after its last earnings report?
Eden Research PLC reported an EPS of -0.002p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.754%.
Which hedge fund is a major shareholder of Eden Research PLC?
Currently, no hedge funds are holding shares in GB:EDEN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Eden Research PLC
Eden Research plc is a UK-based company that operates in the agricultural sector, specializing in the development and commercialization of sustainable biopesticides and natural products. The company primarily focuses on providing eco-friendly solutions for crop protection and enhancing plant health, catering to the increasing demand for sustainable agricultural practices. Eden's core products include natural formulations derived from plant-based materials, aimed at reducing reliance on synthetic chemicals in farming.
Technical Analysis
Options Prices
Currently, No data available
---